Literature DB >> 33419108

The Total Antioxidant Status, Serum Selenium Concentrations and the Ultrasound Assessment Carotid Intima Media Thickness in Patients with Arterial Hypertension.

Paweł Gać1,2, Małgorzata Poręba3, Lidia Januszewska1, Adam Prokopowicz4, Helena Martynowicz5, Grzegorz Mazur5, Rafał Poręba5.   

Abstract

The objective of the study was to establish the correlation between serum selenium concentrations, total antioxidant status, and the carotid intima media thickness in ultrasound assessment in patients with arterial hypertension. A group of 76 people suffering from arterial hypertension was qualified to participate in the study. The mean age of the respondents was 53.48 ± 12.78. Serum selenium concentrations (Se-S) and total antioxidant status (TAS) were determined in all respondents. Se-S were determined by hydride generation atomic absorption spectroscopy (HGAAS). The antioxidant status was assessed by the enzyme-linked immunosorbent assay (ELISA). In addition, an ultrasound exam of the carotid arteries was performed, and the intima media thickness (cIMT) was measured. In the study group, Se-S and TAS were 89.73 ± 18.99 µg/L and 1.18 ± 0.35 mM. However, the cIMT measured using ultrasound was 0.68 ± 0.15 mm. cIMT was significantly greater in patients with arterial hypertension with Se-S < median in comparison to patients with arterial hypertension with Se-S ≥ median (0.73 ± 0.19 mm vs. 0.65 ± 0.10 mm, p < 0.05), as well as in patients with arterial hypertension with TAS < median than in patients with arterial hypertension with TAS ≥ median (0.79 ± 0.18 mm vs. 0.56 ± 0.13 mm, p < 0.05). In regression analysis, older age, higher BMI, smoking, and lower serum selenium concentrations were independently correlated with the greater cIMT. Higher BMI and smoking were independent risk factors for the lower TAS, and the use of ACE inhibitors, β-blockers, and higher Se-S were independent factors of protection against the lower TAS. In patients with arterial hypertension, the lower total antioxidant status due to lower serum selenium concentrations may be correlated with an increase of the carotid intima media thickness measured using ultrasound.

Entities:  

Keywords:  antioxidant status; arterial hypertension; carotid arteries; intima media thickness; selenium

Year:  2021        PMID: 33419108      PMCID: PMC7825395          DOI: 10.3390/antiox10010063

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  38 in total

1.  Total antioxidant status reduction conditioned by a serum selenium concentration decrease as a mechanism of the ultrasonographically measured brachial artery dilatation impairment in patients with arterial hypertension.

Authors:  Paweł Gać; Dominika Urbanik; Natalia Pawlas; Małgorzata Poręba; Helena Martynowicz; Adam Prokopowicz; Lidia Januszewska; Iwona Markiewicz-Górka; Aleksandra Jaremków; Grzegorz Mazur; Rafał Poręba; Krystyna Pawlas
Journal:  Environ Toxicol Pharmacol       Date:  2020-01-24       Impact factor: 4.860

Review 2.  Carotid Intima-Media Thickness for Atherosclerosis.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2015-10-13       Impact factor: 4.928

3.  Blood pressure levels and hypertension prevalence in a high selenium environment: results from a cross-sectional study.

Authors:  M Vinceti; R Chawla; T Filippini; C Dutt; S Cilloni; R Loomba; A Bargellini; N Orsini; K S Dhillon; P Whelton
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-01-24       Impact factor: 4.222

4.  Interaction between blood selenium concentration and a levels of oxidative stress and antioxidative capacity in healthy children.

Authors:  Paweł Gać; Natalia Pawlas; Rafał Poręba; Małgorzata Poręba; Iwona Markiewicz-Górka; Lidia Januszewska; Zofia Olszowy; Krystyna Pawlas
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-30       Impact factor: 4.860

5.  The dependence between urinary mercury concentration and carotid arterial intima-media thickness in workers occupationally exposed to mercury vapour.

Authors:  Anna Skoczyńska; Rafał Poreba; Aleksandra Steinmentz-Beck; Helena Martynowicz; Anna Affelska-Jercha; Barbara Turczyn; Anna Wojakowska; Iwona Jedrychowska
Journal:  Int J Occup Med Environ Health       Date:  2009       Impact factor: 1.843

6.  Serum zinc concentrations and incident hypertension: new findings from a population-based cohort study.

Authors:  Setor K Kunutsor; Jari A Laukkanen
Journal:  J Hypertens       Date:  2016-06       Impact factor: 4.844

Review 7.  Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

Authors:  Ning Wang; Hor-Yue Tan; Sha Li; Yu Xu; Wei Guo; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

Review 8.  ESC Council on hypertension position document on the management of hypertensive emergencies.

Authors:  Bert-Jan H van den Born; Gregory Y H Lip; Jana Brguljan-Hitij; Antoine Cremer; Julian Segura; Enrique Morales; Felix Mahfoud; Fouad Amraoui; Alexandre Persu; Thomas Kahan; Enrico Agabiti Rosei; Giovanni de Simone; Philippe Gosse; Bryan Williams
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2019-01-01

9.  Effect of metabolic control on oxidative stress, subclinical atherosclerosis and peripheral artery disease in diabetic patients.

Authors:  Ozra Tabatabaei-Malazy; Hossein Fakhrzadeh; Farshad Sharifi; Mojde Mirarefin; Seyed Masoud Arzaghi; Zohre Badamchizadeh; Mahtab Alizadeh Khoee; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2015-11-10

10.  Complex contaminant mixtures and their associations with intima-media thickness.

Authors:  Eric N Liberda; Aleksandra M Zuk; Leonard J S Tsuji
Journal:  BMC Cardiovasc Disord       Date:  2019-12-12       Impact factor: 2.298

View more
  1 in total

1.  Oxidative Stress in Association with Metabolic Health and Obesity in Young Adults.

Authors:  Grzegorz K Jakubiak; Kamila Osadnik; Mateusz Lejawa; Sławomir Kasperczyk; Tadeusz Osadnik; Natalia Pawlas
Journal:  Oxid Med Cell Longev       Date:  2021-06-26       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.